Literature DB >> 30940521

Genomic signature of early T-cell response is associated with lower antibody titer threshold for sterilizing immunity.

Eugenia Z Ong1, Esther S Gan1, Ruklanthi de Alwis1, Limin Wijaya2, Xin Mei Ong1, Menglan Zhang3, Abigail Wl Wong2, Yin Bun Cheung4, Raphaël M Zellweger1, Eng Eong Ooi5, Jenny G Low6.   

Abstract

Vaccination is an effective approach to reduce disease burden. High vaccination coverage blocks pathogen transmission to ensure herd immunity. However, the concept of herd immunity assumes that vaccinated individuals cannot be infected and mediate silent pathogen transmission. While the correlates of vaccine-mediated protection against disease have been examined, the correlates of sterilizing immunity that prevents infection have not been systematically defined. Here, we used full genome expression profiling to explore the molecular correlates of serological response and non-response to measles, mumps and rubella (MMR) vaccination as surrogates of infection and sterilizing immunity, respectively. We observed that the antibody titers needed to sterilize infection with the vaccine strains were higher than current WHO disease protection thresholds. In subjects with baseline antibodies below such sterilizing immunity thresholds, serological non-response to MMR vaccination was associated with gene expression profile indicative of early T-cell activation and signalling. Specifically, genes that regulate T-cell function and response were induced at day 1 post-vaccination in non-responders but not in responders. These findings suggest that rapid T-cell response prevented MMR vaccine infection to limit antigenic presentation and hence serological response. Collectively, our findings suggest an important role for T-cells in engendering sterilizing immunity.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cellular immunity; Early T-cells response; Genomic signature; Measles mumps and rubella (MMR) vaccine; Sterilizing immunity

Mesh:

Substances:

Year:  2019        PMID: 30940521     DOI: 10.1016/j.antiviral.2019.03.013

Source DB:  PubMed          Journal:  Antiviral Res        ISSN: 0166-3542            Impact factor:   5.970


  3 in total

1.  Mumps virus-specific immune response outcomes and sex-based differences in a cohort of healthy adolescents.

Authors:  Marguerite M Riggenbach; Iana H Haralambieva; Inna G Ovsyannikova; Daniel J Schaid; Gregory A Poland; Richard B Kennedy
Journal:  Clin Immunol       Date:  2021-12-28       Impact factor: 3.969

2.  A Dynamic Immune Response Shapes COVID-19 Progression.

Authors:  Eugenia Ziying Ong; Yvonne Fu Zi Chan; Wan Ying Leong; Natalie Mei Ying Lee; Shirin Kalimuddin; Salahudeen Mohamed Haja Mohideen; Kian Sing Chan; Anthony Tanoto Tan; Antonio Bertoletti; Eng Eong Ooi; Jenny Guek Hong Low
Journal:  Cell Host Microbe       Date:  2020-04-30       Impact factor: 21.023

Review 3.  Mumps Outbreaks in Vaccinated Populations-Is It Time to Re-assess the Clinical Efficacy of Vaccines?

Authors:  Anna R Connell; Jeff Connell; T Ronan Leahy; Jaythoon Hassan
Journal:  Front Immunol       Date:  2020-09-18       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.